Financials

News Ideas Technicals

PMCN-M fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PHARMOCANN GLOBAL operating, investing, and financing activities

PMCN-M free cash flow for H2 23 is 35 k ILS. For 2023, PMCN-M free cash flow was -4.91 M ILS and operating cash flow was -4.88 M ILS.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: ILS

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—